Alec Stranahan
Stock Analyst at B of A Securities
(0.79)
# 3,710
Out of 4,735 analysts
27
Total ratings
38.89%
Success rate
-23.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $28 → $25 | $12.24 | +104.25% | 4 | Jan 7, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $13 → $11 | $1.52 | +623.68% | 1 | Jan 7, 2025 | |
| ERAS Erasca | Upgrades: Buy | $5 | $1.90 | +163.16% | 2 | Jan 7, 2025 | |
| CATX Perspective Therapeutics | Downgrades: Neutral | $24 → $6 | $3.52 | +70.45% | 2 | Nov 25, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $48 → $55 | $40.16 | +36.95% | 3 | Jul 16, 2024 | |
| NVAX Novavax | Maintains: Neutral | $12 → $18 | $8.81 | +104.31% | 3 | Jun 14, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $118 → $140 | $151.55 | -7.62% | 3 | May 25, 2023 | |
| XNCR Xencor | Initiates: Buy | $42 | $20.45 | +105.38% | 1 | May 19, 2023 | |
| YMAB Y-mAbs Therapeutics | Maintains: Neutral | $6 → $12 | $6.19 | +93.86% | 4 | May 15, 2023 | |
| TGTX TG Therapeutics | Maintains: Underperform | $5 → $6 | $29.86 | -79.91% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $60 → $5 | $2.04 | +145.10% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $36.35 | +23.80% | 1 | Dec 1, 2022 |
Day One Biopharmaceuticals
Jan 7, 2025
Maintains: Buy
Price Target: $28 → $25
Current: $12.24
Upside: +104.25%
Caribou Biosciences
Jan 7, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $1.52
Upside: +623.68%
Erasca
Jan 7, 2025
Upgrades: Buy
Price Target: $5
Current: $1.90
Upside: +163.16%
Perspective Therapeutics
Nov 25, 2024
Downgrades: Neutral
Price Target: $24 → $6
Current: $3.52
Upside: +70.45%
Revolution Medicines
Jul 16, 2024
Maintains: Buy
Price Target: $48 → $55
Current: $40.16
Upside: +36.95%
Novavax
Jun 14, 2024
Maintains: Neutral
Price Target: $12 → $18
Current: $8.81
Upside: +104.31%
Krystal Biotech
May 25, 2023
Maintains: Buy
Price Target: $118 → $140
Current: $151.55
Upside: -7.62%
Xencor
May 19, 2023
Initiates: Buy
Price Target: $42
Current: $20.45
Upside: +105.38%
Y-mAbs Therapeutics
May 15, 2023
Maintains: Neutral
Price Target: $6 → $12
Current: $6.19
Upside: +93.86%
TG Therapeutics
Dec 29, 2022
Maintains: Underperform
Price Target: $5 → $6
Current: $29.86
Upside: -79.91%
Dec 2, 2022
Downgrades: Underperform
Price Target: $60 → $5
Current: $2.04
Upside: +145.10%
Dec 1, 2022
Initiates: Buy
Price Target: $45
Current: $36.35
Upside: +23.80%